The discordance of HER2 status between CTCs and primary tumour has been demonstrated in other work, which also indicates that the phenomenon of heterogeneity between CTCs within individual patients, in regards to HER2, also exists as it does for ERα/PgR [264, 265]. This evidence concerns the gene PGR and neoplasm.